Navigation Links
Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
Date:4/29/2009

468,457 434,037 ------- ------- Costs and expenses: Cost of revenue 301,725 273,330 Reimbursed out-of-pocket expenses 27,221 21,605 Selling, general and administrative 63,954 59,017 Depreciation and amortization 19,614 17,348 ------ ------ Total costs and expenses 412,514 371,300 ------- ------- Income from operations 55,943 62,737 Other (income) expense, net: Interest income, net (83) (2,596) Foreign exchange transaction gain, net (446) (1,065) Gain on sale of business - (2,978) -- ------ Other income, net (529) (6,639) (a) ---- ------ Income before taxes and equity investee earnings 56,472 69,376 (a) Taxes on income 16,349 20,723 (a) Equity investee earnings 172 449 ------- ------- Net income $40,295 $49,102 (a) ======= ======= Basic earnings per share $0.63 $0.78 (a) Weighted average shares outstanding - basic 63,586,418 63,312,592 Diluted earnings per share $0.63 $0.76 (a) Weighted average shares outsta
'/>"/>
SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Covance Opens New Clinical Development Offices in Chile, Peru and Expands Argentina Office
2. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
3. Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
4. Covance Purchases Equity Stake in Caprion Proteomics
5. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
6. Covance Decides to Pursue Its Original Preclinical Strategy in China
7. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
8. Covance to Present at The R.W. Baird 2008 Growth Stock Conference
9. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
11. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2007 Financial Results Conference Call

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009).... 25 /PRNewswire/ - Cytochroma today announced the...irectors. Dr. Moldt will replace Mr. Ulrik Spork a...rd. The number of Board members remains unchanged ...ome Peter Moldt to the board and look forward to b...chroma continues to make progress in becoming a le...
(Date:11/25/2009)... 25 Ardea Biosciences, I... Quart, Pharm.D., president and chief executive of...al Health Care Conference. , ,Presentation detail...h Care Conference,Date: Tuesday, December 1, ...The New York Palace Hotel, New York, NY,Webcast: ...
(Date:11/24/2009)...bassador to also Visit Detroit , ...id Appia, French Ambassador for International Inve...ce Agency, , , , ,What: Ambassador Appia is avail...ness initiatives adopted by France to further deve...or innovation and development., , ,When: Available...
(Date:11/24/2009)...HEIM, Ontario, Nov. 24 D...ring the assets of Hyland Seeds, a division of Tho...of Hyland Seeds will further expand Dow AgroScienc...tes the introduction of SmartStax(TM) in 2010 ...chnology in corn in 2012. The transactional close ...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...orporation,announced today that it has entered int...HP, Nasdaq: SHPGY, TSX: SHQ), to jointly develop A...n in various gastrointestinal,("GI") disorders. Sh... of,AT-1001 outside of the United States and Japan...1001 in the United States and Japan., Under the t...
...f,directors of Abbott today declared a quarterly c...ks the 336th consecutive quarterly dividend to be ...yable Feb. 15, 2008, to,shareholders of record at ...as increased its dividend payout for 35 consecutiv...er this year -- and was named to the,2007 Fortune ...
...euticals, Inc. (Nasdaq: ISIS ) today announced th...rshall, J.D. to Chief Operating Officer,effective ...Chief Financial,Officer, and is a Director of the ...ppropriately reflects the scope,of Lynne,s respons...,Ph.D., Isis, President and CEO. "Lynne has been a...
Other Biology Technology:Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001 2Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001 3Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer 2Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer 3
(Date:11/25/2009)...isch, Head of the Cell Death Research Laboratory i... has been awarded the prestigious Johnson & Johnso... the cause of brain cell damage in Parkinson,s dis...entists in support of innovation and excellence in...nferred earlier this month at an event at the Hyat...
(Date:11/25/2009)...University assistant professors recently received ... to continue research beneficial to understanding ..., Christopher Blackwood, assistant professor in ... grants to support two separate research projects....Decomposer Communities and Functions from the Leaf...
(Date:11/24/2009)...rch Institute (LRI) today named 12 new grant recip... recognize innovative work across a broad spectrum...eativity, novelty, and potential to drive scientif...e the complex disease of systemic lupus. , The 2...searchers across the nation and include interdisci...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Kent State University professors focus research on the environment with grants totaling $890,000 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Schofield Media Names Brian Reshefsky Group President 56972 1Coast Dental Deploys Demandforce D3 Communications Platform 56970 1Coast Dental Deploys Demandforce D3 Communications Platform 56970 2Discovery May Pave Way to Better Diabetes Care 56967 1
...lephants dont carry photo identification, so scien...ndias Nature Conservation Foundation are providing...phic archive of individual elephants, which can he...veloped a unique photographic capture-recapture su...nts, specifically by the shape and size of their t...
...Antonio)Its been more than 100 years since anyone ...sen Sea, but that is about to change. Next month ...ence teacher will join a crew of 22 researchers fr...pedition. , The trip, funded by a $533,000 Natio...A, is designed to study the relationship of sea ic...
...sts have discovered a key protein in the toxic bra...yndrome (FXTAS), an inherited neurodegenerative di...of FXTAS, could help unravel the complex mechanism...s to target the protein. The research will be pub... , Fragile X tremor/ataxia syndrome was first rec...
Other Biology News:Male elephants get 'photo IDs' from scientists 2Texas researchers and educators head for Antarctica 2Scientists link fragile X tremor/ataxia syndrome to binding protein in RNA 2
...,• High specific activity and processivity r...erhang ,• Processes ,A thermostable DNA...rimer extension and other molecular biology applic...lot has been functionally tested for maximal activ...
...,• High specific activity and processivity r...verhang ,• Processes ,A thermostable DN...primer extension and other molecular biology appli... lot has been functionally tested for maximal acti...
Taq DNA Polymerase (Thermus aquaticus) from GE Healthcare, formerly Amersham Biosciences
Mango-Taq DNA Polymerase from Bioline
Biology Products: